Literature DB >> 9434794

Hypochlorite-modified LDL: chemotactic potential and chemokine induction in human monocytes.

C Woenckhaus1, A Kaufmann, D Bussfeld, D Gemsa, H Sprenger, H J Gröne.   

Abstract

Within blood vessels the accumulation of monocytes/macrophages at sites of modified lipoproteins is an important feature in atherosclerosis. Recently the presence of LDL and other proteins modified by hypochlorous acid (HOCl-LDL) was demonstrated in human atherosclerotic vessels and human inflammatory kidney disease by immunohistology and protein chemistry. Chemokines contribute to a specific and directed migration of inflammatory cells. IL-8 (alpha-chemokine) attracts mainly neutrophils and distinct T-cell subsets while MCP-1 (beta-chemokine) preferentially acts on monocytes/macrophages. In the present study it was postulated that HOCl-LDL may induce and amplify inflammatory reactions by the induction of chemokine synthesis in local monocytes. After exposure of human monocytes to HOCl-LDL, it was found that mRNA and protein of the chemokine IL-8 was strongly induced, while the chemokine MCP-1 was not. HOCl-LDL itself led to a chemotactic migration of neutrophils. A chemotactic response of human monocytes toward HOCl-LDL was not detectable. We propose that HOCl-LDL may represent a form of LDL modification in the atherosclerotic process which initiates leukocyte infiltration; these mononuclear cells have been observed in the early stages of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9434794     DOI: 10.1006/clin.1997.4453

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Urate attenuates oxidation of native low-density lipoprotein by hypochlorite and the subsequent lipoprotein-induced respiratory burst activities of polymorphonuclear leukocytes.

Authors:  S Kopprasch; K Richter; W Leonhardt; J Pietzsch; J Grässler
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

Review 2.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

3.  Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein.

Authors:  A C Carr; T Tijerina; B Frei
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

Review 4.  Role of myeloperoxidase in inflammation and atherosclerosis (Review).

Authors:  Christian Frangie; Jalil Daher
Journal:  Biomed Rep       Date:  2022-05-06

5.  Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis.

Authors:  Sander S Rensen; Yanti Slaats; Jeroen Nijhuis; Anneke Jans; Veerle Bieghs; Ann Driessen; Ernst Malle; Jan Willem Greve; Wim A Buurman
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

Review 6.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.